Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.53 CAD | +2.68% | +1.32% | -14.53% |
Sales 2024 * | 1M 734K | Sales 2025 * | 8.12M 5.96M | Capitalization | 116M 85.14M |
---|---|---|---|---|---|
Net income 2024 * | -34M -24.94M | Net income 2025 * | -39M -28.61M | EV / Sales 2024 * | 116 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 14.3 x |
P/E ratio 2024 * |
-3.85
x | P/E ratio 2025 * |
-4.16
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.1% |
Latest transcript on Oncolytics Biotech Inc.
1 day | +2.68% | ||
1 week | +1.32% | ||
1 month | +4.08% | ||
3 months | +6.99% | ||
6 months | -26.09% | ||
Current year | -14.53% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11-05-10 |
Kirk Look
DFI | Director of Finance/CFO | - | 03-03-31 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 22-09-06 |
Patricia Andrews
BRD | Director/Board Member | 66 | Jan. 08 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 15-06-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-27 | 1.53 | +2.68% | 10,099 |
24-05-24 | 1.49 | +2.76% | 21,600 |
24-05-23 | 1.45 | -2.68% | 31,143 |
24-05-22 | 1.49 | -1.32% | 31,560 |
Delayed Quote Toronto S.E., May 27, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.53% | 85.1M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+43.74% | 40.47B | |
-10.87% | 27.17B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- ONC Stock